MAIA Biotechnology, Inc.
MAIA
$1.26
-$0.10-7.35%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.40M | -22.34M | -16.17M | -19.70M | -23.25M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.05M | 562.50K | -668.30K | 3.79M | 8.79M |
| Change in Net Operating Assets | 1.50M | 6.04M | 1.07M | -406.10K | -1.24M |
| Cash from Operations | -18.84M | -15.73M | -15.77M | -16.32M | -15.70M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.52M | 18.58M | 14.92M | 19.64M | 18.97M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -617.10K | -632.60K | -579.30K | -723.00K | -795.20K |
| Cash from Financing | 17.91M | 17.95M | 14.34M | 18.92M | 18.18M |
| Foreign Exchange rate Adjustments | -5.10K | -16.30K | -6.00K | -9.00K | -21.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -943.30K | 2.20M | -1.43M | 2.59M | 2.45M |